These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7616438)

  • 1. Proarrhythmia of a class Ic drug: suppression by combination with a drug prolonging repolarization in the dog late after infarction.
    Duff HJ; Stemler M; Thannhauser T; Laganiere S; Rude E; Lester W
    J Pharmacol Exp Ther; 1995 Jul; 274(1):508-15. PubMed ID: 7616438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
    Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and incidence of inducible monomorphic ventricular tachycardia in a postinfarction rabbit model.
    McLachlan CS; McGuire MA
    J Electrocardiol; 2007 Jan; 40(1):89-93. PubMed ID: 17027019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
    Duff HJ
    J Pharmacol Exp Ther; 1989 May; 249(2):617-22. PubMed ID: 2724143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
    Nelson SD; Coyne KS; Meimer J
    J Pharmacol Exp Ther; 1995 Apr; 273(1):315-9. PubMed ID: 7536244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of systematic programmed ventricular stimulation after myocardial infarction. Which protocol should be recommended?].
    Brembilla-Perrot B; de La Chaise AT; Beurrier D; Martin N; Thiel B; Suty-Selton C; Louis P
    Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1453-7. PubMed ID: 8010843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial ischemia and induction of sustained ventricular tachyarrhythmias: evaluation using dobutamine stress echocardiography-electrophysiologic testing.
    Stambler BS; Akosah KO; Mohanty PK; Wood MA; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):901-7. PubMed ID: 15333083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained polymorphic arrhythmias induced by programmed ventricular stimulation have prognostic value in patients receiving defibrillators.
    Greenberg SL; Mauricio Sánchez J; Cooper JA; Cain ME; Chen J; Gleva MJ; Lindsay BD; Smith TW; Faddis MN
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1067-75. PubMed ID: 17725748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction.
    Wallace AA; Stupienski RF; Kothstein T; Gehret JR; Lynch JJ
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):397-404. PubMed ID: 7681500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological mechanisms of action of the levorotatory isomer of sotalol in a canine infarct model of inducible ventricular tachycardia: comparison with the beta-1 receptor antagonist bisoprolol.
    Aidonidis I; Rizos I; Hilbel T; Kuebler W; Brachmann J
    J Mol Cell Cardiol; 1994 Jul; 26(7):841-8. PubMed ID: 7966352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ventricular tachycardia of ischemic cardiomyopathies].
    Leclercq JF
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):739-46. PubMed ID: 8267501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors for cardiac mortality in cases of syncope with previous history of myocardial infarction].
    Brembilla-Perrot B; Suty-Selton C; Alla F; Beurrier D; Houriez P; Claudon O; Terrier de la Chaise A; Louis P; Sadoul N; Andronache M; Miltjoen H; Juillière Y
    Arch Mal Coeur Vaiss; 2003 Dec; 96(12):1181-6. PubMed ID: 15248444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitation of reentry by lidocaine in canine myocardial infarction.
    Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
    Acta Physiol Hung; 1994; 82(3):201-13. PubMed ID: 7717083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction.
    Mont L; Cinca J; Blanch P; Blanco J; Figueras J; Brotons C; Soler-Soler J
    J Am Coll Cardiol; 1996 Dec; 28(7):1670-6. PubMed ID: 8962550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia.
    Bello D; Fieno DS; Kim RJ; Pereles FS; Passman R; Song G; Kadish AH; Goldberger JJ
    J Am Coll Cardiol; 2005 Apr; 45(7):1104-8. PubMed ID: 15808771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.